Tumor-induced dysfunction in T lymphocytes: Increased sensitivity to apoptosis

Urologe - Ausgabe A

Volumn 43, Issue SUPPL. 2, 2004, Pages

  Finke, J H ^a   Tannenbaum, C ^a   Storkus, W ^b   Rayman, P ^a   Das, T ^a,c   Biswas, K ^a   Richmond, A ^a   Moon, C ^a   Thornton, M ^a   Gill, I ^a   Novick, A ^a   Bukowski, R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; CERAMIDE GLUCOSYLTRANSFERASE; GLYCOSPHINGOLIPID; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CELL INTERACTION; CELL ISOLATION; CONFERENCE PAPER; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NICK END LABELING; OXIDATIVE STRESS; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THIN LAYER CHROMATOGRAPHY; TUMOR CELL; TUMOR IMMUNITY; WESTERN BLOTTING;

ALDEHYDES; APOPTOSIS; CARCINOMA, RENAL CELL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; GANGLIOSIDES; HUMANS; IN SITU NICK-END LABELING; KIDNEY NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 4744366694     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-004-0600-z     Document Type: Conference Paper

References (6)

1. Finke JH, Rayman P, George R, Uzzo R,Tannenbaum CS, Kolenko V, Novick AC, Bukowski RM (2002) Tumor induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma; role of NFxB suppression in this process. Clin Cancer Res 7:940-946
2. Kudo D, Rayman P, Norton C, Cathcart MK, Bukowski RM, Thornton M, Tannenbaum C, Finke JH (2003) Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res 63:1676-1683
3. Molto L, Rayman P, Paszkiewicz-Kozik E, Thornton M, Reese L, Bukowski R, Finke J, Tannenbaum C (2003) The Bcl-2 transgene protects T cells from RCC-mediated apoptosis. Clin Cancer Res 9:4060-4068
4. Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, Finke JH, Bukowski RM, Mueller-Berghalus J, Kirkwood JM, Kwok WW, Storkus WJ (2002) Disease-associated bias in T helper type 1 (Th1)/ Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB 1040 (+) patients with renal cell carcinoma and melanoma. J Exp Med 196:619-628
5. Tatsumi T, Herrem G, Olson WC, Finke JH, Bukowski RM, Kinch MS, Ranieri E, Storkus WL (2003) Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Cancer Res 63:4481-4489
6. Ritter G, Livingston PO (1991) Ganglioside antigens expressed by human cancer cells. Semin Cancer Biol 2:401-409